CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.66 CNY | +0.60% |
|
+9.03% | +28.31% |
| Apr. 29 | Kanghong Pharmaceutical's Unit Gets US FDA's Green Light to Test Macular Degeneration Drug | MT |
| Apr. 29 | Kanghong Pharmaceutical's Unit Gets Nod to Trial Macular Degeneration Drug | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 4.3B 595M | Sales 2025 * | 4.95B 685M | Capitalization | 21.75B 3.01B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.22B 168M | Net income 2025 * | 1.46B 202M | EV / Sales 2024 * | 5.06 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.4 x |
| P/E ratio 2024 * |
17.9
x | P/E ratio 2025 * |
14.9
x | Employees | 4,289 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.62% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.60% | ||
| 1 week | +9.03% | ||
| Current month | +9.03% | ||
| 1 month | +36.21% | ||
| 3 months | +42.79% | ||
| 6 months | +32.55% | ||
| Current year | +28.31% |
1 week
21.90
24.20
1 month
16.7224.20
Current year
13.1524.20
1 year
13.1524.20
3 years
11.9525.48
5 years
11.9552.60
10 years
8.3854.15
| Managers | Title | Age | Since |
|---|---|---|---|
Jian Jun Zhong
DFI | Director of Finance/CFO | 57 | - |
Xiao Ke
PSD | President | 41 | 11-12-31 |
Jin Qun Yin
BRD | Director/Board Member | 52 | 13-06-20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jian Rong Zhong
BRD | Director/Board Member | 67 | 11-12-31 |
Zun Hong Ke
CHM | Chairman | 70 | 97-12-31 |
Xiao Ke
PSD | President | 41 | 11-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | +3.63% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 23.66 | +0.60% | 16,436,400 |
| 24-05-09 | 23.52 | -0.13% | 19,774,390 |
| 24-05-08 | 23.55 | -1.38% | 22,826,280 |
| 24-05-07 | 23.88 | +4.92% | 23,622,240 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotes
Chengdu Kanghong Pharmaceutical Group Co., Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent medicines, chemical drugs and biological products. The Companyâs main products include Conbercept Ophthalmic Injection, Songling capsules conducive to blood vessels, Keluoxin capsules, venlafaxine hydrochloride capsules and sustained release tablets, aripiprazole tablets and orally disintegrating tablets, mosapride citrate tablets and dispersible tablets, dexzopiclone tablets, Shuganjieyu capsules, Danshu capsules and Yiqing capsules, among others. The Company distributes its products in domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-16
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
D-
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
23.66
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +28.31% | 3.01B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| -2.71% | 159B |
- Stock Market
- Equities
- 002773 Stock
